Lamar ZS, Fino N, Palmer J, Gruber L, Morris BB, Raetskaya-Solntseva O, Kennedy L, Vaidya R, Hurd D, Zamkoff K. Dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (EPOCH) with or without rituximab as first-line therapy for aggressive non-Hodgkin lymphoma. Clin Lymphoma Myeloma Leuk. 2016;16(2):76-81.
Lamar ZS, Fino N, Hurd D, Howard D, McIver ZA, Phillips GL, Vaidya R. Timing of salvage therapy and autologous hematopoietic cell transplant in relapsed hodgkin and non hodgkin lymphoma [abstract]. Biol Blood Marrow Transplant. 2016;22(3 Suppl 1):S127-S128.
Lamar ZS, Fitzgerald N, Palmer JM, Gruber L, RaetskayaSolntseva O, Kennedy L, Vaidya R, Zamkoff KW, Hurd DD. Single institution retrospective study of infusional etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin, (EPOCH) plus /- rituximab (R) as first line therapy for aggressive non-Hodgkin lymphoma [abstract]. J Clin Oncol. 2015;33(15 Suppl):e19514.
Lamar Z, Kennedy L, Kennedy B, Lynch M, Goad A, Hurd D, McIver Z. Ibrutinib and rituximab induced rapid response in refractory Richter syndrome. Clin Case Rep. 2015;3(7):615-617.
Mokhtari S, Colletti EJ, Sanada C, Lamar ZS, Simmons PJ, Atala A, Krause DS, Zanjani ED, Porada CD, Almeida-Porada G. A human bone marrow-derived stromal cell population with hemogenic potential [abstract]. Blood. 2015;126(23):1201.
Naik S, D'Agostino R Jr, Lamar Z, Graham RM, Vatca M, Agnew E, Higgins A, Levitan D, Hurd D. Outcomes of second transplants for disease recurrence or for myelodysplasia (MDS) developing after an initial transplant (Tx) [abstract]. Biol Blood Marrow Transplant. 2012;18(2 Suppl 2):S340-S341.
Lamar ZS, Nunez M. Higher risk of severe drug-induced liver injury among Hispanic HIV-infected patients after initiation of highly active antiretroviral therapy. J Int Assoc Physicians AIDS Care (Chic Ill). 2011;10(3):183-186.
Lamar Z, Lesser GJ. Management of meningeal neoplasms: meningiomas and hemangiopericytomas. Curr Treat Options Oncol. 2011;12(3):230-239.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.
The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.
I have complete faith in Dr. Lamar, she is the best.
Dr. Lamar is an excellent doctor who cares about her patients. Very patient and caring. I feel that I got the best care I could have possibly received from her. Love her!!
Dr Lamar is WONDERFUL
*Dr. Lamar rocks!
All of Dr Lamar's team were exceptional. I never want to go through this cancer treatment with a transplant again, but should I have to, I'd want her team taking care of me.
I had a great experience
I love *Dr. Lamar I could not ask for a better more concerned person.
Cat is wonderful. She's as informed and helpful as Dr.Lamar, who is also wonderful.
Dr Lemar is wonderful. I am so thankful that she is my doctor!!!!!
Dr. Lamar is great.
Was there 20 days last visit. Had excellent care entire time.
Excellent dr. & facility.